Combination treatment for acute ischemic stroke: A ray of Hope? (Q36951411)

17 August 2017

title

Combination treatment for acute ischemic stroke: A ray of Hope? (English)

1 reference

17 August 2017

S C Fagan

1

1 reference

17 August 2017

M P Bowes

series ordinal

2

1 reference

17 August 2017

S A Berri

series ordinal

3

1 reference

17 August 2017

J A Zivin

series ordinal

4

1 reference

17 August 2017

publication date

1 November 1999

1 reference

Journal of Stroke and Cerebrovascular Diseases

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

359-367

1 reference

Tissue plasminogen activator for acute ischemic stroke

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

The biologic basis for the treatment of acute stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Neurochemical characterization of excitotoxin lesions in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Origin of intracellular Ca2 elevation induced by in vitro ischemia-like condition in hippocampal slices

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Basic mechanisms of traumatic brain damage

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Cell-permeant Ca2 chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Background review and current concepts of reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Quantitative studies on the influence of leukocytes on the vascular resistance in a skeletal muscle preparation.

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Tissue destruction by neutrophils

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome After Embolic Stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Pharmacologic Studies of the Neuroprotective Actions of a Glutamate Antagonist in Ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combination Chemotherapy Extends the Therapeutic Window to 60 Minutes After Stroke

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Effect of a prostacyclin derivative (OP-41483) and a hyperosmotic agent (glycerol) on brain edema and metabolism in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Indomethacin, prostacyclin, and heparin improve postischemic cerebral blood flow without affecting early postischemic granulocyte accumulation

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

CGS-19755 is neuroprotective during repetitive ischemia: this effect is significantly enhanced when combined with hypothermia

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

Post-ischemic therapy with CGS-19755 (alone or in combination with hypothermia) in gerbils

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

The concept of combination therapy in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016/S1052-3057(99)80043-3

7 January 2021

10.1016/S1052-3057(99)80043-3

Identifiers

DOI

1 reference

release_ayki3lrbmjgxjo6pbczsr3lp7y

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ayki3lrbmjgxjo6pbczsr3lp7y

24 November 2022

mapped directly with Wikidata item

1 reference